News
22h
India Today on MSNWhy White Blood Cells were used to study genetic past and future of IndiansWhile other countries have used saliva, umbilical cord, or skin cells to extract DNA, Indian scientists have used White Blood ...
Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, ...
New research suggests that decreased activity of ELOVL2 -- a key enzyme in lipid metabolism -- accelerates white blood cell aging and alters genes associated with the onset of blood cancers.
11h
News-Medical.Net on MSNNeutrophil subpopulations could help predict autoimmune disease relapseNeutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, ...
Drugs harnessing the power of white blood cells in the immune system can be used to treat certain cancers and autoimmune diseases ...
Scientists have discovered how chemokines and G protein-coupled receptors selectively bind each other to control how cells move.
The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.
News Medical on MSN7d
Key enzyme found to influence immune aging and B cell productionInadequate ELOVL2 changes the balance of lipids in cells, impairing the development of B cells, the lymphocytes (white blood cells) responsible for making antibodies to fight off infection. The ...
RAPID-CRISPR test quickly and accurately diagnoses acute promyelocytic leukemia, a rare and aggressive blood cancer, with high sensitivity.
A new study in the peer-reviewed journal Stem Cells and Development highlights the potential of mesenchymal stem cell (MSC)-derived extracellular vesicles (EVs) as a therapeutic strategy for high-dose ...
The movement of cells in the human body – known as cell migration – is crucial for immune cells. These cells must move quickly and flexibly in different environments in order to fulfil their role as ...
Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results